...
首页> 外文期刊>The Indian journal of tuberculosis >A rare case of coexistence of allergic bronchopulmonary aspergillosis (ABPA) and active pulmonary tuberculosis- Role of CBNAAT in ABPA evaluation
【24h】

A rare case of coexistence of allergic bronchopulmonary aspergillosis (ABPA) and active pulmonary tuberculosis- Role of CBNAAT in ABPA evaluation

机译:一种罕见的过敏性支气管瓣曲霉病(ABPA)和活性肺结核 - CBNAAT在ABPA评估中的作用的罕见案例

获取原文
获取原文并翻译 | 示例
           

摘要

Allergic bronchopulmonary aspergillosis (ABPA) first described by Hinson et al in 1952 is an immune-mediated inflammatory disease caused by hypersensitivity to Aspergillus fumigates that occurs predominantly in patients with underlying chronic airway disorders like bronchial asthma & cystic fibrosis [1,2]. In India pulmonary tuberculosis (PTB) is one of the most common chronic pulmonary infections. Among tubercular patients most of the reported cases of ABPA are among previously treated patients [3] and the others are cases of ABPA misdiagnosed as pulmonary tuberculosis [4]. The occurrence of ABPA in patients with active pulmonary tuberculosis has been rarely reported. Here we present a rare case of 80 years old male patient in which active pulmonary TB and ABPA were present simultaneously. This was possible only because of use of Cartridge based nucleic acid amplification test (CBNAAT) to rule out active pulmonary TB during ABPA evaluation.
机译:1952年首先首先由仁康等人描述的过敏性支气管肺胰岛病(ABPA)是一种免疫介导的炎症疾病,其对曲霉病毒的过敏症引起的,其主要是支气管哮喘等支气管哮喘和囊性纤维化等患者患者[1,2]。 在印度肺结核(PTB)是最常见的慢性肺部感染之一。 结核病患者中的大多数报告的ABPA病例是先前治疗的患者[3],其他人是ABPA被误诊为肺结核的病例[4]。 据报道,患有活性肺结核患者ABPA的发生。 在这里,我们提出了罕见的80岁男性患者,其中同时存在活性肺结核和ABPA。 这仅是因为使用基于筒的核酸扩增试验(CBNAAT)来排除在ABPA评估期间的活性肺结核TB。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号